Summary
Therapy with vincristine (2 mg i.v. weekly) and prednisolone (100 mg p.o. daily) caused a decrease in fibrinogen levels in nine patients treated for lymphoid blast crisis (LBC) of chronic myeloid leukemia (CML). During the first days of treatment disseminated intravascular coagulation (DIC), evidenced by a positive ethanol gelation test, markedly increased thrombin-antithrombin III complex and fibrin-split product D-dimer levels, and a rapid fall in fibrinogen levels was observed in two patients. The induction of DIC in these two patients caused profuse bleeding in one and necessitated substitution therapy with fibrinogen and platelet concentrates. The remaining seven patients revealed no signs of DIC; nevertheless, four of them showed a moderate increase in D-dimer levels after initiation of therapy. In these patients a well-known side effect of long-term steroid therapy, namely a decrease of fibrinogen levels, was observed within the first week of treatment. Fibrinogen levels did not fall below 150 mg/dl and increased after dose reduction from 100 mg/day to 50 mg/day. We conclude from our results that two types of disturbances in fibrinogen metabolism can be observed during vincristine/prednisolone therapy of LBC of CML: (a) a decrease of fibrinogen levels due to a steroid-mediated impairement of liver synthesis, and (b) a rapid fall in fibrinogen levels in the course of DIC, most likely induced by the release of procoagulants from detoriorating blast cells, leading to severe bleeding in selected cases.
Similar content being viewed by others
References
Alpidovsky WK (1967) Procoagulant and fibrinolytic properties of hemocytoblasts and their effect on the expression of hemorrhagic syndrome in patients with acute leukemia. Prog Hematol 12: 24–28
Avvisati G, Büller HR, Ten Cate JW, Mandelli F (1989) Tranexamic acid for control of haemorrhage in acute promyelocytic leukemia. Lancet 2: 122–124
Bauer KA, Rosenberg RD (1984) Thrombin generation in acute promyelocytic leukemia. Blood 64: 791–796
Ben-Zeev D, Schwartz SO, Friedman IA (1966) Promyelocyticmyelocytic leukemia as a terminal manifestation of chronic granulocytic leukemia. Report of a case. Blood 27: 863–870
Bettelheim P, Lutz D, Majdic O, Paietta E, Haas O, Linkesch W, Neumann E, Lechner K, Knapp W (1985) Cell lineage heterogeneity in blast crisis of chronic myeloid leukemia. Br J Haematol 59: 395–409
Cattan A, Amiel J, Schlumberger JR, Schneiger M, Schwarzenberg L, Mathe G (1966) Roles de cellule leucémiques dans l'apparition des phenomenes hemmorrhagiques au cours des leucémies aigues. Nouv Rev Fr Hematol 1: 705–712
Champion LA, Luddy RE, Schwartz AD (1978) Disseminated intravascular coagulation in childhood acute lymphocytic leukemia with poor prognostic features. Cancer 41: 1642–1646
Champlin RE, Golde DW (1985) Chronic myelogeneous leukemia: recent advances. Blood 65: 1039–1047
Chorba TL, Orenstein JM, Ney AB, Schwartz BS, Alabaster O, Kessler CM, Cohen P, Schulhof RS (1985) Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity. Cancer 55: 675–681
Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17: 237–246
Falanga A, Alessio MG, Donati MB, Barbui T (1988) A new procoagulant in acute leukemia. Blood 71: 870–875
Fischer M, Lechner K, Hinterberger W, Niessner H, Pabinger I, Dudczak R, Neumann E, Korninger C, Deutsch E (1985) Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with antithymocyte globulin and high-dose methylprednisolone. Scand J Haematol 34: 312–314
Garg SK, Niemetz J (1973) Tissue factor activity of normal and leukemic cells. Blood 42: 729–735
German HJ, Smith JA, Lindenbaum J (1976) Chronic intravascular coagulation associated with chronic myelocytic leukemia. Use of heparin in connection with a surgical procedure. Am J Med: 547–552
Gingrich RD, Burns CP (1979) Disseminated coagulopathy in chronic myelomonocytic leukemia. Cancer 44: 2249–2253
Godal HC, Abildgard U (1966) Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol 3: 342–346
Gouault-Heilmann M, Chardon E, Sultan C, Josso F (1975) The procoagulant factor of leukemic promyelocytes: demonstration of immunologic cross-reactivity with human tissue factor. Br J Haematol 30: 151–158
Gralnick HR, Marchesi S, Givelber H (1972) Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities. Blood 40: 709–718
Hirsh J, Buchanan JG, De Gruchy GC, Baikie AG (1967) Hypofibrinogenemia without increased fibrinolysis in leukemia. Lancet 1: 418–420
Imakoa S, Ueda T, Shibata H, Masaoka T, Sasaki Y, Iwanaga T, Terasawa T (1986) Fibrinolysis in patients with acute promyelocytic leukemia and disseminated intravascular coagulation during heparin therapy. Cancer 58: 1736–1738
Jorgenson KA, Sorensen P, Freund L (1982) Effect of glucocorticoids on some coagulation tests. Acta Haematol 68: 39–42
Leavey RA, Kahn SB, Brodsky I (1970) Disseminated intravascular coagulation — a complication of chemotherapy in acute myelomonocytic leukemia. Cancer 62: 142–145
Lisiewicz J (1988) Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost 14: 339–350
Pochedly C (1969) Unusual manifestation of chronic granulocytic leukemia in a child. Cancer 24: 1017–1020
Seligman BR, Rosner F, Solomon RB (1975) Chronic myelogenous leukemia: disseminated intravascular coagulation and chloromas containing sea-blue histiocytes. NY State J Med 75: 1271–1274
Speiser W, Pabinger-Fasching I, Kyrle PA, Kapiotis S, Kottas-Heldenberg A, Bettelheim P, Lechner K (1991) Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysis. Blut 61: 298–302
Sterrenberg L, Haak HL, Brommer EJP, Nieuwenhuizen W (1985) Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia. Haemostasis 15: 126–133
Wada H, Negano T, Tomeoko M, Kuto M, Katitani J, Deguchi K, Shirawaka S (1982) Coagulant and fibrinolytic activities in the leukemic cell lysates. Thromb Res 30: 315–322
Whittaker JA, Khurshid M (1982) Hypofibrinogenemia as a cause of bleeding in chronic myeloid leukemia. Br Med J 1: 495–496
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sunder-Plaßmann, G., Speiser, W., Korninger, C. et al. Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia. Ann Hematol 62, 169–173 (1991). https://doi.org/10.1007/BF01703143
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01703143